CN104473896B - 一种快速崩解的拉米夫定片及其制备工艺 - Google Patents
一种快速崩解的拉米夫定片及其制备工艺 Download PDFInfo
- Publication number
- CN104473896B CN104473896B CN201410720088.4A CN201410720088A CN104473896B CN 104473896 B CN104473896 B CN 104473896B CN 201410720088 A CN201410720088 A CN 201410720088A CN 104473896 B CN104473896 B CN 104473896B
- Authority
- CN
- China
- Prior art keywords
- lamivudine
- coating
- pill
- pvpp
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410720088.4A CN104473896B (zh) | 2014-12-01 | 2014-12-01 | 一种快速崩解的拉米夫定片及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410720088.4A CN104473896B (zh) | 2014-12-01 | 2014-12-01 | 一种快速崩解的拉米夫定片及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104473896A CN104473896A (zh) | 2015-04-01 |
CN104473896B true CN104473896B (zh) | 2017-04-19 |
Family
ID=52748602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410720088.4A Active CN104473896B (zh) | 2014-12-01 | 2014-12-01 | 一种快速崩解的拉米夫定片及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104473896B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107334743B (zh) * | 2016-07-15 | 2020-04-21 | 安徽贝克生物制药有限公司 | 一种齐多夫定、拉米夫定、奈韦拉平复方片及其制备方法 |
CN107349185B (zh) * | 2016-07-15 | 2019-11-26 | 安徽贝克生物制药有限公司 | 一种恩曲他滨片剂以及制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007068934A2 (en) * | 2005-12-14 | 2007-06-21 | Cipla Limited | Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
CN102258497A (zh) * | 2011-08-18 | 2011-11-30 | 海南良方医药有限公司 | 一种拉米夫定片剂及其制备方法 |
CN103181910A (zh) * | 2011-12-30 | 2013-07-03 | 北京协和药厂 | 一种拉米夫定片剂及其制备方法 |
WO2013164257A1 (en) * | 2012-04-30 | 2013-11-07 | F. Hoffmann-La Roche Ag | New formulation |
WO2013177672A1 (en) * | 2012-05-31 | 2013-12-05 | Pharmascience Inc. | Pharmaceutical composition of entecavir and process of manufacturing |
CN103908456A (zh) * | 2012-12-29 | 2014-07-09 | 安徽贝克生物制药有限公司 | 替诺福韦、拉米夫定和依非韦伦三联复方微丸片及其制备方法 |
-
2014
- 2014-12-01 CN CN201410720088.4A patent/CN104473896B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007068934A2 (en) * | 2005-12-14 | 2007-06-21 | Cipla Limited | Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
CN102258497A (zh) * | 2011-08-18 | 2011-11-30 | 海南良方医药有限公司 | 一种拉米夫定片剂及其制备方法 |
CN103181910A (zh) * | 2011-12-30 | 2013-07-03 | 北京协和药厂 | 一种拉米夫定片剂及其制备方法 |
WO2013164257A1 (en) * | 2012-04-30 | 2013-11-07 | F. Hoffmann-La Roche Ag | New formulation |
WO2013177672A1 (en) * | 2012-05-31 | 2013-12-05 | Pharmascience Inc. | Pharmaceutical composition of entecavir and process of manufacturing |
CN103908456A (zh) * | 2012-12-29 | 2014-07-09 | 安徽贝克生物制药有限公司 | 替诺福韦、拉米夫定和依非韦伦三联复方微丸片及其制备方法 |
Non-Patent Citations (1)
Title |
---|
司他夫定缓释微丸胶囊的研究;苏龙;《中国优秀硕士学位论文全文数据库医药卫生科技辑》;20061231;第22页1.1部分,44页小结部分 * |
Also Published As
Publication number | Publication date |
---|---|
CN104473896A (zh) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5775464B2 (ja) | 非晶質cddo−meを含有する遅延放出性経口投薬組成物 | |
CN103550165B (zh) | 一种含有利伐沙班的药物组合物及其制备方法 | |
CN103655570B (zh) | 西格列汀与二甲双胍复方缓释制剂及其制备方法 | |
CN107669683B (zh) | 含有西格列汀与二甲双胍的药物组合物 | |
WO2021238978A1 (zh) | 含硝羟喹啉前药的药物组合物及其制备方法和应用 | |
CN110037994A (zh) | 一种布洛芬速释缓释双层片及其制备方法 | |
CN107334772B (zh) | 一种抗逆转录病毒药物组合物 | |
CN104473896B (zh) | 一种快速崩解的拉米夫定片及其制备工艺 | |
CN103271890B (zh) | 盐酸普拉克索胶囊及其制备方法 | |
CN105434386A (zh) | 一种含有高水溶性活性成分的缓释片剂及其制备方法 | |
CN105343028A (zh) | 一种诺氟沙星的药物组合物及其制备方法 | |
AU2020327255A1 (en) | Pharmaceutical composition containing nitroxoline, nitroxoline oral solid tablet, preparation method therefor and use thereof | |
CN106511291A (zh) | 一种盐酸阿考替胺缓释片剂及其制备方法 | |
CN104825449A (zh) | 含有阿托伐他汀钙和氨氯地平的复方组合物及其制备方法 | |
CN103505460B (zh) | 一种制备氯沙坦钾氢氯噻嗪组合物的方法 | |
CN107868009B (zh) | 一种酒石酸美托洛尔晶体及含该晶体的药物组合物及其制备方法 | |
CN106265548A (zh) | 一种卡马西平分散片的制备方法 | |
CN103007286B (zh) | 一种托伐普坦的固体药物组合物 | |
CN111467317B (zh) | 一种含有阿托伐他汀钙的药物组合物及其制备方法 | |
CN107405342A (zh) | 一种含有二胺衍生物或其盐的固体药物组合物 | |
CN102949406B (zh) | 一种复方艾夫他滨药物组合物及其制备方法和用途 | |
CN103845332A (zh) | 一种达沙替尼药用组合物及其制备方法 | |
CN103505466A (zh) | 含有盐酸二甲双胍与格列美脲的固体复方制剂及其制备方法和用途 | |
CN102641253B (zh) | 缬沙坦缓释片及其制备方法 | |
CN103349656B (zh) | 一种缬沙坦胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 523808 Dongguan science and Technology Development Zone, Songshan Lake, Guangdong Province, science and technology, No. two road, No. 7 Applicant after: DONGGUAN JINMEIJI PHARMA CO.,LTD. Address before: 523000 Dongguan hi tech Industrial Development Zone, science and technology, No. two road, No. 7, Guangdong Applicant before: DONGGUAN JINMEIJI PHARMA CO.,LTD. |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Xiaobing Inventor after: Li Shihua Inventor after: Fu Jing Inventor before: Wang Juming |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170320 Address after: 523000 Dongguan hi tech Industrial Development Zone, science and technology, No. two road, No. 7, Guangdong Applicant after: DONGGUAN JINMEIJI PHARMA CO.,LTD. Address before: 211200 Lishui City, Nanjing province Yong Yang Town Economic Development Zone, No. 18, No. Applicant before: Wang Juming |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |